Strengthening Licensing Valuation: Crafting a Winning Case through a Triangulated Methodology
Reading Time: 2 minutes In the high-stakes environment of pharmaceutical licensing, winning a successful bid requires a valuation that is both aggressive and defensible. Our recent case study focuses on clinical and commercial valuation of “Drug X“, a blinded Phase 2 KRAS inhibitor. Omnitheia’s strategic framework is designed to provide a comprehensive valuation for assets…
View details
